What people are saying - Write a review
We haven't found any reviews in the usual places.
Worldwide Prevalence of Use
12 other sections not shown
12 months adolescents amenorrhoea associated bleeding disorders bleeding patterns bone density breast cancer breast milk calcium carcinoma centres cervical cancer changes chromosomal anomalies clinical trial cohort control group Depo users Depo-Provera contraceptive Depo-Provera group Depo-Provera users depot medroxyprogesterone acetate discontinuation DMPA dose duration effect of Depo-Provera endometrial atrophy endometrium estrogen etal ex-Depo users exposed to Depo-Provera exposure Family Planning ferritin ferritin levels Force on Long-Acting galactorrhoea haemoglobin hormonal contraceptives Human Reproduction ICMR India Indian women infants injectable contraceptives lactation lipid long-term menstrual cycle method multinational NET-EN Norplant oral contraceptives ovarian ovulation Pardthaisong period population pregnancy progesterone progestin progestogens Programme of Research received Depo-Provera relative risk reported Research Training return of fertility risk of breast significant significantly Special Programme steroid contraceptives study carried Task Force Thailand three monthly tion Training in Human Upjohn USFDA utero vaginal woman women using Depo-Provera World Health Organization